Lilly's stock price hit a record high when it opened on October 29. It is now reported at $1383.885, a record high. It has now risen 7.46%. At one point, the opening increase was more than 8%. The cumulative increase over the past year was about 59.36%, and the company's market value reached about 1.15 trillion US dollars. Eli Lilly's revenue increased by 49.58% over the past 12 months, and the increase in sales of diet pills and diabetes drugs became the focus of market attention.

Lilly's stock price hit a record high when it opened on October 29. It is now reported at $1383.885, a record high. It has now risen 7.46%. At one point, the opening increase was more than 8%. The cumulative increase over the past year was about 59.36%, and the company's market value reached about 1.15 trillion US dollars. Eli Lilly's revenue increased by 49.58% over the past 12 months, and the increase in sales of diet pills and diabetes drugs became the focus of market attention.